News and feature stories about the Department of Neurology at the Indiana University School of Medicine.
IU neurologist's research leads to first FDA-approved drug to treat neurofibromatosis type 1
Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported significant improvements in pain severity and overall health-related quality of life.
June 10, 2025
The blood test is for adults 55 and older who exhibit symptoms and is the first of its kind, with more than 90% effectiveness.
June 09, 2025
ALS researcher aims to discover hidden causes of neuromuscular disease on quest for new therapies
ALS Awareness Month: Brian Pierchala, PhD, is growing ALS research at IU School of Medicine through the Motoneuron Club and collaborative science.May 02, 2025
Indiana patients are among the first people in the country to receive new disease-modifying drugs for Alzheimer's disease, contributing to the work of IU School of Medicine researchers actively studying the long-term effects of the treatments.
April 24, 2025
A multicenter study led by Kaustubh Limaye, MD, an associate professor of clinical neurology at the IU School of Medicine, found that a novel device used to surgically treat patients with large vessel occlusions — a severe type of ischemic stroke — is a safe and effective way to remove blood clots in the brain.
April 23, 2025
Parkinson's researchers discover 'tip of the ICE-berg' on quest for a cure
Parkinson's researcher Malú Tansey brings cell-level science to IU’s already strong clinical research program. Her lab engages in "paradigm-shifting work" studying inflammation and immune response in Parkinson's.March 31, 2025
Neurology Annual Reports
Media Inquiries
Media interested in interviewing neurology experts are encouraged to contact the Office of Strategic Communications.